Allopurinol Tablet
Product Images NDC 43063-976

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Allopurinol (NDC 43063-976). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063976 Label (43063976)

43063976 Label (43063976)
This is a description of a medication with NDC code 43063-976-30 in tablet form, with each tablet containing 300mg of Aulopurinol USP. The medication is manufactured by D: Pharmaceuticals Incorporated and the dosage and storage information can be found in the package insert. The medication comes in a bottle of 30 tablets and the recommended dosage is to take the tablet(s) prescribed by a doctor a certain number of times a day. The label provides a warning to keep the medication out of the reach of children and advises contacting a doctor for medical advice on side effects. The label also provides the option to report side effects to the FDA. The medication is scored and the GTIN is 0343063976302. The rest of the text is not legible.*
FDA Label Image

Structure (Allopurinol 01)

FDA Label Image

Figure (Allopurinol 02)

Figure (Allopurinol 02)
Allopurinol is a medication which is converted into Oxipurinol. The chemical structure includes pyrazolo-pyrimidine and 4.6-dione. It acts to lower levels of uric acid in the body by inhibiting the production of hypoxanthine and xanthine. It is also used to prevent gout and kidney stones.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.